Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109691801000001110 | Oxybutynin 5mg modified-release tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109691901000001116 | Oxybutynin 5mg modified-release tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Oxybutynin 5mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Oxybutynin 5mg modified-release tablets 30 tablet | Has VMP | False | Oxybutynin 5mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Lyrinel XL 5mg tablets (Waymade Healthcare Plc) | Is a | False | Oxybutynin 5mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) | Is a | False | Oxybutynin 5mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Ditropan XL 5mg tablets (Janssen-Cilag Ltd) | Is a | False | Oxybutynin 5mg modified-release tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR